Mary J. MacKenzie

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Johann S. de Bono, Stéphane Oudard, Mustafa Özgüroğlu et al. · The Lancet · 2010 · 3.3K citations

Medicine, Oncology, Pharmacology +16

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · The Lancet Oncology · 2013 · 1K citations · Full text

Medicine, Biostatistics, Oncology +14

Imatinib Mesylate in Patients With Adenoid Cystic Cancers of the Salivary Glands Expressing c-kit: A Princess Margaret Hospital Phase II Consortium Study

Sebastién J. Hotte, Eric Winquist, Elizabeth B. Lamont et al. · Journal of Clinical Oncology · 2005 · 280 citations

Medicine, Oncology, Cancer Pharmacology +13

Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy

Rana R. McKay, Nils Kroeger, Wanling Xie et al. · European Urology · 2013 · 253 citations · Full text

Medicine, Oncology, Pharmacology +16

Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria

Nils Kroeger, Wanling Xie, Jae‐Lyn Lee et al. · Cancer · 2013 · 232 citations · Full text

Medicine, Oncology, Genitourinary Oncology +15